Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PF-07921188 by BioNTech for Herpes Zoster (Shingles): Likelihood of Approval
PF-07921188 is under clinical development by BioNTech and currently in Phase II for Herpes Zoster (Shingles). According to GlobalData, Phase...